# Dermata Therapeutics, Inc.: Form 8-K, filed Jul 16, 2025

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: 8-K
- Filed: 2025-07-16
- Accepted by EDGAR: Jul 15, 2025, 17:45 ET
- Period: 2025-07-15
- Accession: 0001641172-25-019760
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000164117225019760/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000164117225019760/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000164117225019760/form8-k.htm

Filed Jul 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-019760. Last ingested by Listed: Nov 2, 2026, 18:37 ET. No prices; not investment advice.